Provisional Agreement on EU Pharmaceutical Refo...

By João L. Carapinha

December 12, 2025

Provisional Deal Ushers in EU Pharmaceutical Reform The European Parliament and Council have reached a provisional agreement to overhaul the EU's pharmaceutical policy framework, m...
Advancing EU Health Technology Assessment: Key Priorities in the HTACG Draft ...
WHO Guidelines Set New Standard for GLP-1 Obesity Therapies in Adults
Biomanufacturing Excellence Act: Strengthening U.S. Biopharmaceutical Manufac...
Enhancing Efficiency in FAST-EU Clinical Trials: A New Era for Biomedical Res...
Patient-Reported Outcomes Trends in Clinical Trials: Insights from 2008-2023
Koselugo EU Approval: A Milestone in Treating Plexiform Neurofibromas for Adu...
Medical Schemes Affordability Crisis: Insights from the CMS Annual Report 202...
Aligning Medical Schemes with National Health Insurance South Africa
Obesity Health Economics: Forecasting Trends and Costs in the US
Guiding the Future of Digital Cardiac Rehabilitation: NICE’s Conditiona...
Unlocking Self-Care South Africa: Strategies and Challenges in Healthcare Reform
Rare Medications Coverage in the Netherlands: Price Reductions Required